THILO SCHROEDER

Profile

First Name

: THILO

Middle Name

:

Last Name

: SCHROEDER

Related Companies
Titles
Company Name
Related People
DIRECTOR
BLUEPRINT MEDICINES CORP
JEFFREY W. ALBERS, CHRISTINE BELLON, ALEXIS BORISY, STEPHEN KNIGHT, KYLE KUVALANKA, CHRISTOPH S. LENGAUER, NICHOLAS LYDON, NICK LYDON, DANIEL LYNCH, DAVID SCHENKEIN
DIRECTOR
IMAGINAB, INC.
JEFF BAILEY, CHRISTIAN BEHRENBRUCH, ISAAC BRIGHT, VALERIE CALENDA, ABBIE CELNIKER, BENJAMIN CHEN, MARTYN COOMBS, RICHARD DING, K. LEONARD JUDSON, JENNIFER KEPPLER, JOSEPH LIMBER, CAMPBELL MURRAY, JEFFREY D. QUAN, ANNA W. WORK, ANNA M. WU
DIRECTOR
IDEAYA BIOSCIENCES, INC.
BRIAN DANIELS, JOHN DIEKMAN, JOHN D. DIEKMAN, MICHAEL P. DILLON, JEFFREY HAGER, YUJIRO HATA, YUJIRO S. HATA, EDWARD HU, TERRY ROSEN, TIMOTHY SHANNON, TIM SMITH, JEFFREY STEIN, PAUL STONE, PAUL A. STONE
DIRECTOR
REVOLUTION MEDICINES, INC.
ELIZABETH ANDERSON, MICHAEL BONNEY, ALEXIS BORISY, NEIL EXTER, MARK A. GOLDSMITH, MARGARET HORN, STEVE KELSEY, LAURENCE LASKY, RYAN MARTINS, VINCENT MILLER, BARBARA WEBER, LUAN WILFONG
DIRECTOR
SILVERBACK THERAPEUTICS, INC.
VICKIE L. CAPPS, ROBERT HERSHBERG, SAQIB ISLAM, SCOTT PLATSHON, JONATHAN ROOT, LAURA SHAWVER, PETER THOMPSON, PETER A. THOMPSON
DIRECTOR
CIRCLE PHARMA, INC.
DOUGLAS CRAWFORD, DAVID EARP, DAVID J. EARP, JAMES EVANGELISTA, MATTHEW JACOBSON, MATTHEW P. JACOBSON, JOHN JOSEY, STEPHEN KELSEY, SCOTT R. LOKEY, CAYLA MCEWEN, WALTER MOOS, WALTER H. MOOS, PAUL PARK, ELTON SATUSKY, PETER SVENNILSON
DIRECTOR
ALTEROME THERAPEUTICS, INC.
RYAN B. CORCORAN, CARL GORDON, ARJUN GOYAL, ERIC A. MURPHY
EXECUTIVE OFFICER
NEXTECH VII ONCOLOGY SCSP
DALIA BLEYER, IAN CHAROUB, COSTAS CONSTANTINIDES, JACOB LOVEN, N/A NEXTECH VII GP S.A R.L., ALFRED SCHEIDEGGER, ROCCO J. SGOBBO
EXECUTIVE OFFICER
NEXTECH CROSSOVER I SCSP
DALIA BLEYER, IAN CHAROUB, COSTAS CONSTANTINIDES, JACOB LOVEN, N/A NEXTECH CROSSOVER I GP S.A R.L., ALFRED SCHEIDEGGER, ROCCO J. SGOBBO
EXECUTIVE OFFICER
NEXTECH VII CARRY SCSP
IAN CHAROUB, COSTAS CONSTANTINIDES, JACOB LOVEN, N/A NEXTECH VII GP S.A R.L., ALFRED SCHEIDEGGER, ROCCO J. SGOBBO
EXECUTIVE OFFICER
NEXTECH CROSSOVER I CARRY SCSP
IAN CHAROUB, COSTAS CONSTANTINIDES, JACOB LOVEN, N/A NEXTECH CROSSOVER I GP S.A R.L., ALFRED SCHEIDEGGER, ROCCO J. SGOBBO
EXECUTIVE OFFICER
NEXTECH VIII SCSP
IAN CHAROUB, COSTAS CONSTANTINIDES, JAKOB HENRIK LOVEN, N/A N/A NEXTECH VIII GP S.A R.L., ROCCO J. SGOBBO
DIRECTOR
STIPPLE BIO, INC.
VINEETA AGARWALA, DEREK DIROCCO, OWEN HUGHES, JEFFREY LANDAU, AARON RING, GREG VERDINE, ANTOINE YVER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-31 
2025-01-10
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2024-10-24
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-18 
2024-08-29
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2024-07-03
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2023-04-13
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-24 
2023-04-13
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-24 
2023-02-16
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-11 
2023-02-16
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-11 
2022-11-15
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-24 
2022-11-15
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-24 
2022-03-22
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-06-15 
2022-01-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-31 
2021-06-29
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-06-15 
2020-10-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-09-22 
2020-03-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-16 
2020-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-04 
2019-11-15
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-06-05 
2018-07-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-23 
2018-05-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-31 
2017-09-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-05 
2016-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2014-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-10 
2014-01-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-06